Health and Me

Rachel V Thomas

Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug To Improve Walking

Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug to Improve Walking

Fampridine, the first medicine designed to improve walking in adults with multiple sclerosis (MS), will now be routinely available on the NHS in England, NHS England has announced.

The twice-daily pill, described as a "signal booster" therapy, is expected to benefit around 5,000 people living with MS in England during its first year of rollout.

“Walking difficulties can have a huge impact on the freedom and independence of people with MS, so this signal-boosting pill could be life-changing for thousands of patients,” said Professor Frankie Swords, NHS National Medical Director.

Until now, treatment for MS-related walking difficulties has largely relied on physiotherapy, exercise, walking aids, foot-support devices, and treatments to manage muscle stiffness.

According to Professor Swords, fampridine helps electrical messages travel along nerves damaged by MS, allowing some people to walk more easily and improve their mobility. For some patients, this could make everyday activities easier, from moving around the house and getting out independently to spending more time with family and friends.

Also read: <a href="https://www.healthandme.com/health-news/nhs-to-roll-out-two-gamechanger-tests-for-faster-endometriosis-diagnosis-know-how-they-work-article-154960552" data-type="tilCustomLink">NHS To Roll Out Two 'Gamechanger' Tests for Faster Endometriosis Diagnosis: Know How They Work</a>

Clinical trials found that fampridine (Fampyra) improved walking speed in 43% of patients and also helped people walk for longer.

Patients will initially take the medicine for two to four weeks, with walking assessed before and after treatment. Those who experience a clear benefit will continue taking it for as long as it remains effective, with regular reviews.

The rollout follows an assessment by NHS England's Clinical Priorities Advisory Group, bringing access in England in line with other UK nations.

Read More: <a href="https://www.healthandme.com/health-wellness/why-multiple-sclerosis-increases-emotional-burden-for-women-article-153778507" data-type="tilCustomLink">Why Multiple Sclerosis Increases Emotional Burden Among Women</a>

More than 120,000 people live with MS in England, and fampridine is the only licensed treatment that helps improve walking ability and speed for some patients.

The drug will be available for adults with any type of MS whose walking difficulties are assessed as having an Expanded Disability Status Scale (EDSS) score between 4 (able to walk without aid or rest for around 500 meters) and 7 (unable to walk further than 5 metres and largely restricted to a wheelchair).

Multiple sclerosis is a lifelong neurological condition caused by damage to nerves in the brain and spinal cord. It is also a chronic autoimmune disease in which the immune system attacks the brain and spinal cord.

Symptoms vary from person to person and may come and go or worsen over time. MS can affect cognitive, emotional, motor, sensory, and visual functions. Symptoms may also worsen during heat exposure or infections such as urinary tract or respiratory infections.

According to the MS International Federation, an estimated 2.8 million people worldwide live with MS, with women accounting for about 75% of cases globally.

<ul><li>Vision problems</li><li>Difficulty walking or maintaining balance</li><li>Difficulty thinking clearly</li><li>Numbness or weakness, especially in the arms and legs</li><li>Muscle stiffness</li><li>Depression</li><li>Problems with sexual function or urination</li><li>Feeling very tired.</li></ul>

Health Conditions A-Z

health

fampridine-nhs-england-rolls-out-first-multiple-sclerosis-drug-to-improve-walking

NHS England

Fampridine

Multiple Sclerosis Drug

Fampyra

autoimmune disease

neurological disease

could-low-self-esteem-fuel-social-anxiety-among-medical-students-new-study-finds-link

Could Low Self-Esteem Fuel Social Anxiety Among Medical Students? New Study Finds Link

can-glp-1-drugs-like-ozempic-mounjaro-cause-hair-loss-study-says-its-rare-but-real

Can GLP-1 Drugs Like Ozempic, Mounjaro Cause Hair Loss? Study Says It's Rare But Real

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Fampridine, the first medicine designed to improve walking in adults with multiple sclerosis (MS), will now be routinely available on the NHS in England, NHS England has announced.The twice-daily pill, described as a "signal booster" therapy, is expected to benefit around 5,000 people living with MS in England during its first year of rollout.“Walking difficulties can have a huge impact on the freedom and independence of people with MS, so this signal-boosting pill could be life-changing for thousands of patients,” said Professor Frankie Swords, NHS National Medical Director.How Does Fampridine Work?Until now, treatment for MS-related walking difficulties has largely relied on physiotherapy, exercise, walking aids, foot-support devices, and treatments to manage muscle stiffness.According to Professor Swords, fampridine helps electrical messages travel along nerves damaged by MS, allowing some people to walk more easily and improve their mobility. For some patients, this could make everyday activities easier, from moving around the house and getting out independently to spending more time with family and friends.Also read: NHS To Roll Out Two 'Gamechanger' Tests for Faster Endometriosis Diagnosis: Know How They WorkEvidence Behind The DrugClinical trials found that fampridine (Fampyra) improved walking speed in 43% of patients and also helped people walk for longer.Patients will initially take the medicine for two to four weeks, with walking assessed before and after treatment. Those who experience a clear benefit will continue taking it for as long as it remains effective, with regular reviews.The rollout follows an assessment by NHS England's Clinical Priorities Advisory Group, bringing access in England in line with other UK nations.Who Is Eligible?Read More: Why Multiple Sclerosis Increases Emotional Burden Among WomenMore than 120,000 people live with MS in England, and fampridine is the only licensed treatment that helps improve walking ability and speed for some patients.The drug will be available for adults with any type of MS whose walking difficulties are assessed as having an Expanded Disability Status Scale (EDSS) score between 4 (able to walk without aid or rest for around 500 meters) and 7 (unable to walk further than 5 metres and largely restricted to a wheelchair).What Is Multiple Sclerosis?Multiple sclerosis is a lifelong neurological condition caused by damage to nerves in the brain and spinal cord. It is also a chronic autoimmune disease in which the immune system attacks the brain and spinal cord.Symptoms vary from person to person and may come and go or worsen over time. MS can affect cognitive, emotional, motor, sensory, and visual functions. Symptoms may also worsen during heat exposure or infections such as urinary tract or respiratory infections.According to the MS International Federation, an estimated 2.8 million people worldwide live with MS, with women accounting for about 75% of cases globally.Common symptoms of MS include:Vision problemsDifficulty walking or maintaining balanceDifficulty thinking clearlyNumbness or weakness, especially in the arms and legsMuscle stiffnessDepressionProblems with sexual function or urinationFeeling very tired.

fampridine: nhs england rolls out first multiple sclerosis drug to improve walking

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug To Improve Walking

Could Low Self-Esteem Fuel Social Anxiety Among Medical Students? New Study Finds Link

Researchers Question WHO's Push For Traditional Medicine; Say Health Body Is Lowering The Bar For Evidence

Many US Veterans With Suicidal Thoughts May Not Be Receiving Mental Health Treatment, Study Finds

Health Conditions A-Z

Fampridine: NHS England Rolls Out First Multiple Sclerosis Drug To Improve Walking

Could Low Self-Esteem Fuel Social Anxiety Among Medical Students? New Study Finds Link

Can GLP-1 Drugs Like Ozempic, Mounjaro Cause Hair Loss? Study Says It's Rare But Real